Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7

6 clinical trials · Condition

Record	Firm	Date
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery (NCT03493425)	ECOG-ACRIN Cancer Research Group	2019-03-12
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma (NCT03422536)	University of Arizona	2017-12-05
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery (NCT02538510)	University of Washington	2015-10-08
Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT02196168)	National Cancer Institute (NCI)	2014-03-01
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617)	National Cancer Institute (NCI)	2011-02-10
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385)	National Cancer Institute (NCI)	2010-11-01

Every clearance here is in the API, with alerts when new ones post.